| Name | Title | Contact Details |
|---|
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Pro-MED is a Coral Springs, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
East Tennessee Children's Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Knoxville, TN. To find more information about East Tennessee Children's Hospital, please visit www.etch.com
Ahura Scientific is a Wilmington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
American Health Care Centers is a Wadsworth, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.